A Novel Transgenic Mouse Model to Study the Osteoblast Lineage in Vivo

Authors


  • Future address (1/08): K.U. Leuven, Laboratory of Experimental Medicine and Endocrinology, Herestraat 49, B-3000 Leuven, Belgium. Voice: 0032-16-345972; fax: 0032-16-345934.
    christa.maes@med.kuleuven.

Address for correspondence: Christa Maes, Ph.D., Harvard Medical School, Massachusetts General Hospital, Endocrine Unit, 50 Blossom Street, Thier 1101, Boston, MA 02114. Voice: 001-617-726-3966; fax: 001-617-726-7543.
cmaes1@partners.org

Abstract

Abstract: Over the past few decades, osteoblast differentiation has been studied extensively in a variety of culture systems and findings from these experiments have shaped our understanding of the bone-forming cell lineage. However, in vitro assays are bound by intrinsic limitations and are unable to effectively mirror many aspects related to osteoblasts in vivo, including their origin, destiny, and life span. Therefore, these fundamental questions strongly advocate the need for novel models to characterize the osteoblast lineage in vivo. Here, we developed a transgenic mouse system to study stage-specific subsets of osteoblast lineage cells. We believe that this system will prove to be a helpful tool in deciphering multiple aspects of osteoblast biology in vivo.

Ancillary